This approval is a key step forward in the development of the company’s iSTRYM digital therapeutics platform VANCOUVER, BC, March 9, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “MINDCURE” or the “Company”) a leader in advanced proprietary technology for psychedelic therapy, is pleased to announce that it has received unconditional ethics approval from Veritas IRB for…


Previous articleMindMed Announces C$19.5 Million Bought Deal Private Placement Offering
Next articleBetter Plant Appoints Branding Expert Perry Chua as Chief Creative Officer